Literature DB >> 17897313

Remission induction with single agent Rituximab in a child with multiply relapsed precursor-B ALL.

Edward S Morris, Ajay Vora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17897313     DOI： 10.1111/j.1365-2141.2007.06814.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Expression of CD20 in B Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Jeevan Kumar; Afaq Ahmad Khan; Amrita Saraf; Manorama Bhargava
Journal:  Indian J Hematol Blood Transfus       Date:  2012-12-06       Impact factor: 0.900

2.  Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression.

Authors:  Patrice Chevallier; Beatrice Mahe; Richard Garand; Pascaline Talmant; Jean-Luc Harousseau; Jacques Delaunay
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

3.  CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.

Authors:  Michael N Dworzak; Angela Schumich; Dieter Printz; Ulrike Pötschger; Zvenyslava Husak; Andishe Attarbaschi; Giuseppe Basso; Giuseppe Gaipa; Richard Ratei; Georg Mann; Helmut Gadner
Journal:  Blood       Date:  2008-09-09       Impact factor: 22.113

Review 4.  Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.

Authors:  Keith J August; Aru Narendran; Kathleen A Neville
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.